Decoy Therapeutics Inc. , a biotechnology company pioneering Designable Multi-Antivirals (D-MAVstm), a new category of antivirals engineered to target shared viral mechanisms, today announced that ...
Pennsylvania is investing $306.4 million through PENNVEST for 29 water and wastewater projects across 23 counties to upgrade aging systems and improve water quality.